CapitalGainsReport: CBD Market Exploding, These Stocks May Benefit

Cannabidiol (CBD) is the legal and non-psychoactive 'cousin' of THC, the chemical responsible for marijuana's psychological effects. Lately, CBD has conquered industry after industry, from food and beverage, to health and beauty.

The CBD market has exploded. The Brightfold Group predicts that it might hit $22 Billion by 2022 in the U.S. alone. Given the entire U.S. organic food market is estimated to reach $70.4 Billion by 2025, this is a mind-blowing figure.

Several companies are making innovations in this fast-growing space that investors should start researching now.

Real Brands Inc. (OTCMKTS:RLBD) is one of the highest potential ways to play the health & wellness boom, a market projected to exceed $6 trillion by 2025.

Reasons to know RLBD:

Market Opportunity is Massive

Health and Wellness projected to exceed $6 Trillion, CBD Market $20 Billion, CBD Beverages $1.3 Billion...with a whopping 43% CAGR!

Expert Management and Directors

Between an expert, C-suite and a Board loaded with executive talent and major independent directors (which you won't find on most OTC boards) experienced in science, consumer-packaged goods, and capital markets, RLBD has the kind of leadership necessary to grow shareholder value to its full potential.

Uplisting Imminent

RLBD has completed the necessary paperwork to complete a QB uplisting. This will help broaden the potential investor base...but may not even be the biggest catalyst based on this already impressive news...

Five Deals" on the Horizon

In a recent interview RLBD CEO noted that once the company's uplisting is effective, the company will have "five" major "deal" announcements. These events could push RLBD to 'brand' new levels. Why could these announcements be bigger than your average OTC company's?

Big Boys Backing Real Brands

Turning Points Brands, Inc. (NYSE: TPB) is a 23% owner of RLBD and has $9 Billion in AUM, private hedge fund Standard General owns around 20% of TPB and has nearly $1 Billion in AUM. David Glazek is chairman of TPB and founded SG so the two companies are aligned. Leveraging investors of this scale increases the potential size of these forthcoming deals.

GrowGeneration Corp (NASDAQ:GRWG) stock has gaining momentum with the broader market. The stock has moved up about 15% in the past week. Revenues grew 46% to $90.6 million in the Q4 and increased 119% to $422.5 million for the full year 2021. Net income for the full year came in at $12.8 million, as compared to $5.3 million previous year.

Net loss during the latest quarter was $4.1 million, compared to net income of $1.5 million in the prior year. The company projects full year 2022 revenue in the range of $415 million - $445 million with adjusted EBITDA of $30 million to $35 million. Moreover, GrowGeneration intends to open 15 to 20 new GrowGeneration garden centers in 2022.

MiMedx Group Inc (NASDAQ:MDXG) Last week the placental biologics firm MiMedx Group had come into focus among investors in a big way after it was announced on March 16 that WoundGenex had gone into a strategic partnership with it. WoundGenex is one of the leading names in the world of wound care.

As per the provisions of the partnership between the two companies, they are going to collaborate on the launch of an exclusive version of Premier Graft Program. The program has been developed by WoundGenex and the exclusive version is going to be made available to clients all over the country.

Innovate (NYSE:VATE) The next company that one needs to look into at this point in time is that of Innovate Corp. There has been no news about the company in recent days but back on March 9 it had come into focus after it announced its financial results for the fourth quarter as well as the fiscal year that had ended on December 31, 2021. The company noted at the time that in 2021 it had managed to continue with its 'strategic transformation' and had also managed to make significant progress. It could be a stock worth tracking at this point.

InnovAge Holding Corp (NASDAQ:INNV): The company reported revenues of $175.4 million, up 11.5% compared to $157.3 million for the second quarter of fiscal 2021, due to an increase in census and per member per month rates. Net income of $1.1 million compared to net income of $9.6 million for the second quarter of fiscal 2021. Adjusted EBITDA of $14.8 million compared to $22.6 million in the second quarter of fiscal 2021.

Planet 13 Holdings Inc (OTCMKTS:PLNHF) is all set to report its financial results for the fourth quarter and year ended December 31st, 2021 on March 28th, 2022 aftermarket. The stock has been gaining momentum ahead of earnings with a jump 28% over the past week. However, despite recent rally, the stock is down 20% so far this year.

Recently, the company announced the completion today of the previously announced arrangement under the Business Corporations Act , pursuant to which Planet 13 acquired all of the issued and outstanding common shares of Next Green Wave.

Disclaimers: Capital Gains Report 'CGR' is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by CGR is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall CGR. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by CGR., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. CGR. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, CGR., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated fifteen thousand dollars via wire transfer by Washington Capital to produce and syndicate content for RLBD. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

CONTACT: To educate and attract more investors contact us at:

Mark McKelvie

[e-mail]

[phone]

.

(C) 2022 M2 COMMUNICATIONS, source M2 PressWIRE